Intra-arterial thrombolytics after endovascular thrombectomy for acute ischemic stroke: A network meta-analysis of RCTs.

J Neurol SciJul 19, 2026 (epub)

Mohamed Elfil, Abdallah Abbas, Haneen Sabet et al.

✦ AI-curated · Sources linked

In 30 seconds

This network meta-analysis evaluated the efficacy and safety of intra-arterial thrombolysis (IAT) after endovascular thrombectomy (EVT) for acute ischemic stroke in 2564 patients across eight randomized controlled trials. The study found that EVT combined with TNK 0.125 mg/kg and ALT 0.225 mg/kg significantly improved excellent outcomes (mRS 0-1) compared to EVT alone, with relative risks of 1.54 and 1.51, respectively.

Key findings

  • EVT + TNK 0.125 mg/kg improved mRS 0-1 outcomes with RR 1.54.
  • EVT + ALT 0.225 mg/kg also improved mRS 0-1 outcomes with RR 1.51.
  • No regimen improved mRS 0-2 or mortality outcomes.
  • EVT + TNK 0.0625 mg/kg increased the risk of any ICH with RR 1.34.

Why it matters

The findings suggest that adjunctive IAT may enhance recovery in patients undergoing EVT for acute ischemic stroke, potentially addressing the issue of futile recanalization without increasing the risk of symptomatic intracranial hemorrhage.

Source

Published in J Neurol Sci. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Neurology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.